465 related articles for article (PubMed ID: 17971048)
1. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
Burfoot RK; Jensen CJ; Field J; Stankovich J; Varney MD; Johnson LJ; Butzkueven H; Booth D; Bahlo M; Tait BD; Taylor BV; Speed TP; Heard R; Stewart GJ; Foote SJ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2008 Jan; 71(1):42-50. PubMed ID: 17971048
[TBL] [Abstract][Full Text] [Related]
2. A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy.
D'Alfonso S; Bolognesi E; Guerini FR; Barizzone N; Bocca S; Ferrante D; Castelli L; Bergamaschi L; Agliardi C; Ferrante P; Naldi P; Leone M; Caputo D; Ballerini C; Salvetti M; Galimberti D; Massacesi L; Trojano M; Momigliano-Richiardi P
Genes Immun; 2008 Jan; 9(1):7-15. PubMed ID: 17928868
[TBL] [Abstract][Full Text] [Related]
3. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
[TBL] [Abstract][Full Text] [Related]
4. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
Fernandez-Morera JL; Rodriguez-Rodero S; Tunon A; Martinez-Borra J; Vidal-Castineira JR; Lopez-Vazquez A; Rodrigo L; Rodrigo P; González S; Lahoz CH; Lopez-Larrea C
Tissue Antigens; 2008 Jul; 72(1):54-9. PubMed ID: 18588574
[TBL] [Abstract][Full Text] [Related]
5. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.
Harbo HF; Lie BA; Sawcer S; Celius EG; Dai KZ; Oturai A; Hillert J; Lorentzen AR; Laaksonen M; Myhr KM; Ryder LP; Fredrikson S; Nyland H; Sørensen PS; Sandberg-Wollheim M; Andersen O; Svejgaard A; Edland A; Mellgren SI; Compston A; Vartdal F; Spurkland A
Tissue Antigens; 2004 Mar; 63(3):237-47. PubMed ID: 14989713
[TBL] [Abstract][Full Text] [Related]
6. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
[TBL] [Abstract][Full Text] [Related]
7. The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis.
Kroner A; Grimm A; Johannssen K; Mäurer M; Wiendl H
Hum Immunol; 2007 May; 68(5):422-5. PubMed ID: 17462509
[TBL] [Abstract][Full Text] [Related]
8. The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR.
Zivković M; Stanković A; Dincić E; Popović M; Popović S; Raicević R; Alavantić D
Clin Chim Acta; 2009 Aug; 406(1-2):27-30. PubMed ID: 19433080
[TBL] [Abstract][Full Text] [Related]
9. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
[TBL] [Abstract][Full Text] [Related]
10. Analysis of IL4R haplotypes in predisposition to multiple sclerosis.
Mirel DB; Barcellos LF; Wang J; Hauser SL; Oksenberg JR; Erlich HA
Genes Immun; 2004 Mar; 5(2):138-41. PubMed ID: 14712310
[TBL] [Abstract][Full Text] [Related]
11. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.
Oksenberg JR; Baranzini SE; Sawcer S; Hauser SL
Nat Rev Genet; 2008 Jul; 9(7):516-26. PubMed ID: 18542080
[TBL] [Abstract][Full Text] [Related]
12. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis.
Rubio JP; Bahlo M; Butzkueven H; van Der Mei IA; Sale MM; Dickinson JL; Groom P; Johnson LJ; Simmons RD; Tait B; Varney M; Taylor B; Dwyer T; Williamson R; Gough NM; Kilpatrick TJ; Speed TP; Foote SJ
Am J Hum Genet; 2002 May; 70(5):1125-37. PubMed ID: 11923913
[TBL] [Abstract][Full Text] [Related]
13. A second component of HLA-linked susceptibility to type 1 diabetes maps to class I region.
Kawabata Y; Ikegami H; Fujisawa T; Noso S; Asano K; Hiromine Y; Ogihara T
Ann N Y Acad Sci; 2006 Oct; 1079():278-84. PubMed ID: 17130566
[TBL] [Abstract][Full Text] [Related]
14. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.
Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K
Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052
[TBL] [Abstract][Full Text] [Related]
15. Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A.
Fdez-Morera JL; Tunon A; Rodriguez-Rodero S; Rodrigo L; Martinez-Borra J; Gonzalez S; Lopez-Vazquez A; Lahoz CH; Lopez-Larrea C
Tissue Antigens; 2006 May; 67(5):409-14. PubMed ID: 16671949
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
[TBL] [Abstract][Full Text] [Related]
17. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.
Rubio JP; Stankovich J; Field J; Tubridy N; Marriott M; Chapman C; Bahlo M; Perera D; Johnson LJ; Tait BD; Varney MD; Speed TP; Taylor BV; Foote SJ; Butzkueven H; Kilpatrick TJ
Genes Immun; 2008 Oct; 9(7):624-30. PubMed ID: 18650830
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
[TBL] [Abstract][Full Text] [Related]
19. Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex.
Aly TA; Baschal EE; Jahromi MM; Fernando MS; Babu SR; Fingerlin TE; Kretowski A; Erlich HA; Fain PR; Rewers MJ; Eisenbarth GS
Diabetes; 2008 Mar; 57(3):770-6. PubMed ID: 18065518
[TBL] [Abstract][Full Text] [Related]
20. The human major histocompatibility complex: 42,221 bp of genomic sequence, high-density sequence-tagged site map, evolution, and polymorphism for HLA class I.
Janer M; Geraghty DE
Genomics; 1998 Jul; 51(1):35-44. PubMed ID: 9693031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
